Article
Dietary fat, abdominal obesity and smoking modulate the relationship between plasma complement component 3 concentrations and metabolic syndrome risk.
Atherosclerosis - 1 Feb 2012
Phillips Catherine M, Kesse-Guyot Emmanuelle, Ahluwalia Namanjeet, McManus Ross, Hercberg Serge, Lairon Denis, Planells Richard, Roche Helen M
Abstract excerpt
OBJECTIVE: Chronic inflammation plays a role in the pathogenesis of metabolic syndrome (MetS) and cardiovascular disease (CVD). Complement component 3 (C3) is a novel cardiometabolic risk factor. Whether dietary fat intake modulates MetS risk conferred by elevated C3 concentrations is unknown. Our objective is to investigate the relationship between C3 concentrations and risk of the MetS and its phenotypes, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
